Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines

Cell Reports

Volumn 14, Issue 4, 2016, Pages 708-722

  Henry, Conor M ^a,c   Sullivan, Graeme P ^a   Clancy, Danielle M ^a   Afonina, Inna S ^a   Kulms, Dagmar ^b   Martin, Seamus J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Cathepsin G; Elastase; IL 17; IL 36; IL family; Inflammation; Neutrophil; Protease; Psoriasis

Indexed keywords

CASPASE 3; CATHEPSIN G; CYTOKINE; ELASTASE; INTERLEUKIN 36ALPHA; INTERLEUKIN 36BETA; INTERLEUKIN 36GAMMA; MYELOBLASTIN; UNCLASSIFIED DRUG; CATHEPSIN; INTERLEUKIN 1; INTERLEUKIN 36, HUMAN;

ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INHIBITION KINETICS; KERATINOCYTE; NEUTROPHIL; NEWBORN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PSORIASIS; REACTION ANALYSIS; CELL CULTURE; ENZYMOLOGY; HELA CELL LINE; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM;

CATHEPSINS; CELLS, CULTURED; HELA CELLS; HUMANS; INTERLEUKIN-1; KERATINOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PSORIASIS;

EID: 84958115094     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.072     Document Type: Article

References (45)

1. Adkison A.M., Raptis S.Z., Kelley D.G., Pham C.T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 2002, 109:363-371.
2. Afonina I.S., Tynan G.A., Logue S.E., Cullen S.P., Bots M., Lüthi A.U., Reeves E.P., McElvaney N.G., Medema J.P., Lavelle E.C., Martin S.J. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. Mol. Cell 2011, 44:265-278.
3. Afonina I.S., Müller C., Martin S.J., Beyaert R. Proteolytic processing of Interleukin-family cytokines: variations on a common theme. Immunity 2015, 42:991-1004.
4. Amulic B., Cazalet C., Hayes G.L., Metzler K.D., Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 2012, 30:459-489.
5. Blumberg H., Dinh H., Trueblood E.S., Pretorius J., Kugler D., Weng N., Kanaly S.T., Towne J.E., Willis C.R., Kuechle M.K., et al. Opposing activities of two novel members of the IL-ligand family regulate skin inflammation. J. Exp. Med. 2007, 204:2603-2614.
6. Blumberg H., Dinh H., Dean C., Trueblood E.S., Bailey K., Shows D., Bhagavathula N., Aslam M.N., Varani J., Towne J.E., Sims J.E. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J. Immunol. 2010, 185:4354-4362.
7. Borregaard N., Sørensen O.E., Theilgaard-Mönch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007, 28:340-345.
8. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
9. Dinarello C.A. Immunological and inflammatory functions of the interleukin-family. Annu. Rev. Immunol. 2009, 27:519-550.
10. Eggers C.T., Murray I.A., Delmar V.A., Day A.G., Craik C.S. The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase. Biochem. J. 2004, 379:107-118.
11. Farooq M., Nakai H., Fujimoto A., Fujikawa H., Matsuyama A., Kariya N., Aizawa A., Fujiwara H., Ito M., Shimomura Y. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum. Mutat. 2013, 34:176-183.
12. Garver R.I., Mornex J.F., Nukiwa T., Brantly M., Courtney M., LeCocq J.P., Crystal R.G. Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes. N. Engl. J. Med. 1986, 314:762-766.
13. Haslett C., Guthrie L.A., Kopaniak M.M., Johnston R.B., Henson P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 1985, 119:101-110.
14. Hubbard R.C., Fells G., Gadek J., Pacholok S., Humes J., Crystal R.G. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J. Clin. Invest. 1991, 88:891-897.
15. Ikeda S., Takahashi H., Suga Y., Eto H., Etoh T., Okuma K., Takahashi K., Kanbara T., Seishima M., Morita A., et al. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J. Am. Acad. Dermatol. 2013, 68:609-617.
16. Johnston A., Xing X., Guzman A.M., Riblett M., Loyd C.M., Ward N.L., Wohn C., Prens E.P., Wang F., Maier L.E., et al. IL-1F5, -F6, -F8, and -F9: a novel IL-family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J. Immunol. 2011, 186:2613-2622.
17. Kanazawa N., Nakamura T., Mikita N., Furukawa F. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis. J. Dermatol. 2013, 40:749-751.
18. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013, 13:159-175.
19. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
20. Korkmaz B., Horwitz M.S., Jenne D.E., Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol. Rev. 2010, 62:726-759.
21. Lefrançais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.P., Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 2012, 109:1673-1678.
22. Maas-Szabowski N., Stark H.J., Fusenig N.E. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 2000, 114:1075-1084.
23. Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S., Zribi J., Bal E., Cluzeau C., Chrabieh M., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 2011, 365:620-628.
24. Meyer-Hoffert U., Wiedow O. Neutrophil serine proteases: mediators of innate immune responses. Curr. Opin. Hematol. 2011, 18:19-24.
25. Milovanovic M., Volarevic V., Radosavljevic G., Jovanovic I., Pejnovic N., Arsenijevic N., Lukic M.L. IL-33/ST2 axis in inflammation and immunopathology. Immunol. Res. 2012, 52:89-99.
26. Murphy M., Kerr P., Grant-Kels J.M. The histopathologic spectrum of psoriasis. Clin. Dermatol. 2007, 25:524-528.
27. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N. Engl. J. Med. 2009, 361:496-509.
28. Onoufriadis A., Simpson M.A., Pink A.E., DiMeglio P., Smith C.H., Pullabhatla V., Knight J., Spain S.L., Nestle F.O., Burden A.D., Capon F., Trembath R.C., et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 2011, 89:432-437.
29. Pham C.T.N. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 2006, 6:541-550.
30. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., Hackney J., Kim J., Zhou M., Lai J., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 2011, 12:1159-1166.
31. Schonthaler H.B., Guinea-Viniegra J., Wculek S.K., Ruppen I., Ximénez-Embún P., Guío-Carrión A., Navarro R., Hogg N., Ashman K., Wagner E.F. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 2013, 39:1171-1181.
32. Sims J.E., Smith D.E. The IL-family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
33. Telfer N.R., Chalmers R.J., Whale K., Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch. Dermatol. 1992, 128:39-42.
34. Terui T., Ozawa M., Tagami H. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp. Dermatol. 2000, 9:1-10.
35. Tortola L., Rosenwald E., Abel B., Blumberg H., Schäfer M., Coyle A.J., Renauld J.C., Werner S., Kisielow J., Kopf M. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 2012, 122:3965-3976.
36. Towne J.E., Sims J.E. IL-36 in psoriasis. Curr. Opin. Pharmacol. 2012, 12:486-490.
37. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., Sims J.E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 2004, 279:13677-13688.
38. Towne J.E., Renshaw B.R., Douangpanya J., Lipsky B.P., Shen M., Gabel C.A., Sims J.E. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J. Biol. Chem. 2011, 286:42594-42602.
39. Vigne S., Palmer G., Lamacchia C., Martin P., Talabot-Ayer D., Rodriguez E., Ronchi F., Sallusto F., Dinh H., Sims J.E., Gabay C. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011, 118:5813-5823.
40. Vigne S., Palmer G., Martin P., Lamacchia C., Strebel D., Rodriguez E., Olleros M.L., Vesin D., Garcia I., Ronchi F., et al. IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells. Blood 2012, 120:3478-3487.
41. Vörsmann H., Groeber F., Walles H., Busch S., Beissert S., Walczak H., Kulms D. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death Dis. 2013, 4:e719.
42. Walsh J.G., Logue S.E., Lüthi A.U., Martin S.J. Caspase-promiscuity is counterbalanced by rapid inactivation of processed enzyme. J. Biol. Chem. 2011, 286:32513-32524.
43. Weiss G., Shemer A., Trau H. The Koebner phenomenon: review of the literature. JEADV 2002, 16:241-248.
44. Wiedow O., Wiese F., Streit V., Kalm C., Christophers E. Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J. Invest. Dermatol. 1992, 99:306-309.
45. Wu J.K., Siller G., Strutton G. Psoriasis induced by topical imiquimod. Australas. J. Dermatol. 2004, 45:47-50.